Podcasts about adalja

Today's show is sponsored by Americans for Free Choice in Medicine -- https://www.afcm.orgDr. Adalja is an expert on infectious disease, emergency preparedness, pandemics, and the intersections of public health and national security. is a board-certified physician in internal medicine, emergency medicine, infectious diseases, and critical care medicine. Dr. Adalja's expertise is frequently sought by international and national media.He has also published in such journals as the New England Journal of Medicine, JAMA, Journal of Infectious Diseases, Clinical Infectious Diseases, Emerging Infectious Diseases, Annals of Emergency Medicine, and Health Security.Dr. Adalja is a Fellow of the Infectious Diseases Society of America, the American College of Physicians, and the American College of Emergency Physicians. He is a member of various medical societies, including the American Medical Association, the HIV Medicine Association, and the Society of Critical Care Medicine.Dr. Adalja is a native of Butler, Pennsylvania, and actively practices infectious disease, critical care, and emergency medicine in the Pittsburgh metropolitan area.Dr. Adalja is the Chairman of the board of Americans for Free Choice in Medicine.Reinier Schuur is the Executive Director of AFCM. He holds a PhD in Philosophy from the University of Birmingham in the United Kingdom, where he specialized in the philosophy of medicine, and a Masters of Science in Philosophy of Psychiatry from King's College London. A native of the Netherlands, Reinier was a visiting Fulbright scholar at New York University and at the University of Pittsburgh. Reinier develops AFCM's educational offerings and collaborates with other organizations to educate the American public about how to advocate for their individual rights in healthcare.Show is Sponsored by The Ayn Rand Institute https://www.aynrand.org/starthereEnergy Talking Points, featuring AlexAI, by Alex Epstein https://alexepstein.substack.com/Express VPN https://www.expressvpn.com/yaronJoin this channel to get access to perks: / @yaronbrook Like what you hear? Like, share, and subscribe to stay updated on new videos and help promote the Yaron Brook Show: https://bit.ly/3ztPxTxSupport the Show and become a sponsor: / yaronbrookshow or https://yaronbrookshow.com/Or make a one-time donation: https://bit.ly/2RZOyJJContinue the discussion by following Yaron on Twitter (https://bit.ly/3iMGl6z) and Facebook (https://bit.ly/3vvWDDC )Want to learn more about Ayn Rand and Objectivism? Visit the Ayn Rand Institute: https://bit.ly/35qoEC3#freemarket #healthcare #Rights #individualism #AynRand #science #philosophyofscience #ethics #selfishness #egoism #capitalism #philosophy #Morality ​ ​#Objectivism​ #politicsBecome a supporter of this podcast: https://www.spreaker.com/podcast/yaron-brook-show--3276901/support.

Dr. Adalja shares his thoughts on the current flu season and future trends in viral infectious diseases. He talks about vaccine misinformation and what he expects to see in 2024. Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. https://centerforhealthsecurity.org/who-we-are/our-people/amesh-adalja-md-fidsa #COVID #RSV #influenza #misinformation #disinformation #vaccines #trust

Anita Adalja, founder of Not Our Farm, sat down with the food safety team to discuss how community care and considerations for farmworkers--the heart of farm operations--lead to healthy work environments, healthy food, happy people, and beyond!ResourcesNot Our Farm WebsiteNot Our Farm Zine: A Guide to Working on FarmsFair Share CSA CoalitionHelp us continually improve! Respond to the Food Safety Dish Survey!

is Sponsored by https://www.expressvpn.com/yaron & https://www.fountainheadcasts.comJoin this channel to get access to perks: https://www.youtube.com/@YaronBrook/joinLike what you hear? Like, share, and subscribe to stay updated on new videos and help promote the Yaron Brook Show: https://bit.ly/3ztPxTxSupport the Show and become a sponsor: https://www.patreon.com/YaronBrookShow or https://yaronbrookshow.com/membershipOr make a one-time donation: https://bit.ly/2RZOyJJContinue the discussion by following Yaron on Twitter (https://bit.ly/3iMGl6z) and Facebook (https://bit.ly/3vvWDDC )Want to learn more about Ayn Rand and Objectivism? Visit the Ayn Rand Institute: https://bit.ly/35qoEC3#covid19 #infectiousdisease #vaccines #philosophy #stoicism #Morality ​ ​#Objectivism​ #AynRand #politicsThis show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/3276901/advertisement

In this episode of The Vivek Show, host Vivek Ramaswamy welcomes Dr. Amesh Adalja, an infectious disease, critical care, and emergency medicine physician with extensive experience in pandemic preparedness. Dr. Adalja shares his journey into the medical field, including his education at Carnegie Mellon and transition from business to medicine. The two discuss the early days of the COVID-19 pandemic, its trajectory, and the challenges faced in risk communication. They also debate pandemic strategies, the effectiveness of vaccines, and the importance of prioritizing protection for high-risk individuals.Dr. Amesh Adalja is an infectious disease, critical care, and emergency medicine physician with expertise in pandemic preparedness. A graduate of Carnegie Mellon, Dr. Adalja has dedicated his career to understanding and combating infectious diseases. As an esteemed medical professional, he provides valuable insights into effectively managing and mitigating the impact of pandemics on global health. Donate here: https://t.co/PE1rfuVBmbFor more content follow me here:Twitter - @VivekGRamaswamyInstagram - @vivekgramaswamyFacebook - http://facebook.com/VivekGRamaswamyTruth Social - @VivekRamaswamyRumble - @VivekRamaswamyTime-codes:00:00 - Introduction09:35 - Criticism from both the left and the right10:41 - Challenges in risk communication12:21 - Identifying the pandemic potential of COVID-1914:38 - Early actions that could have changed the pandemic's trajectory19:46 - Identifying mild COVID-19 cases20:51 - Predicting COVID-19 seasonality22:34 - The effectiveness of contact tracing24:34 - Continued testing problems27:22 - Dr. Adalja's ideal pandemic approach28:22 - Importance of honest communication29:36 - Alternative strategy: natural immunity32:09 - Defending the use of vaccines

After years of using a ZERO COVID strategy in China, which led to many lockdowns and economic questions, the country has dropped all COVID restrictions in recent weeks. Dr. Amesh Adalja of the Johns Hopkins Center for Health Security joins Stephanie Desmon to discuss what has happened in China, what the consequences are now and what they will be in the future. Adalja says both policies were destined to fail and we could see China in 2023 look a lot like the United States in 2020.

By most objective measures, the Covid pandemic is over. Because of impressively rapid technological innovations, most people are now able to easily manage risks to their health posed by the virus. But not everyone agrees that this means the pandemic is over. Some argue that as long as even a handful of high-risk individuals are threatened by Covid, we should not think it proper to resume normal life. What ideas are responsible for this approach to the ethics of infectious disease? What attitude does it betray toward healthy people and toward the innovations that allow us to preserve and perfect it? What has been the impact of this approach? By contrast, what is a rational approach to the ethics of infectious disease? Join Ben Bayer as he interviews Dr. Amesh Adalja to discuss these and other issues addressed by a recent article by Adalja in Areo Magazine.

On today's program: Stephen Moore, FreedomWorks Senior Economic Contributor, offers his analysis of the potential impact of President Biden's anticipated student loan forgiveness announcement and the real world impact of the Inflation Reduction Act.

Monkeypox doesn't spread as easily as many other infectious diseases, says Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security. Adalja compares monkeypox spread within households with other viruses. Adalja: When you look at the household attack rate it doesn't seem to be spreading very easily so for example if you take […]

What's the difference between COVID reinfection, rebounding, and a new infection? Are people contagious and can they have recurring symptoms with a COVID rebound? Can antivirals like paxlovid cause COVID rebounds? Can paxlovid prevent long COVID? Amesh Adalja returns to the podcast to talk with  Josh Sharfstein and answer your questions sent to publichealthquestion@jhu.edu.

In this talk, Dr. Adalja will discuss the science behind vaccine platform technologies such as the mRNA vaccines. He will also describe how changes in the scientific context impact the role of vaccines, the misconception of science as omniscient, and how the arbitrary must play no role in scientific-medical matters. Recorded live on July 6, 2022 as part of the Objectivist Summer Conference

Dr. Amesh Adalja of Johns Hopkins Center for Health Security discusses the latest on Covid testing.

How did omicron numbers affect hospitalization rates? Why are positivity rates so high in some areas, and should we even pay attention to those? How accurate are rapid tests, and how forgiving are they of user error? Are our immune systems more “naive” after two years of physical distancing and masks? Dr. Amesh Adalja from the Center for Health Security returns to the podcast to talk with Lindsay Smith Rogers and answer your questions sent to publichealthquestion@jhu.edu.

Dr. Scott Knoer, PharmD is the CEO of the American Pharmacists Association. Scott has been very vocal about the FDA eliminating barriers to Pharmacists prescribing COVID antivirals and how the American Medical Association (AMA) seeming to be more concerned with their 'turf' and political position compared to the benefit to public health within America. Amesh Adalja, MD wrote in MedPage Today, an article titled: "A Successful 'Test-to-Treat' Program Requires All Hands on Deck" Within the article, Dr. Adalja wrote. In encouraging news, President Biden just announced a new plan to increase faster access: test-to-treat. The plan will enable pharmacies to become one-stop shops for COVID-19 diagnosis and oral antiviral treatment. Having treatment available at the point-of-diagnosis has the potential to significantly improve prescribing rates, which will have the downstream impact of reducing hospitalizations. More sick patients will quickly be able to access treatment. "We can't have a guild-like mentality that seeks to use government force to exclude qualified persons from engaging in a field for which the AMA wants physicians to be the exclusive purveyors. This has been evident in organized medicine's general opposition to expanded practice scopes for nurse practitioners, physician assistants, psychologists, and -- as is clear -- pharmacists. It's bad enough to advocate for this on a day-to-day basis. To do so during a public health emergency, where all hands are needed on deck, is destructive." -- Amesh Adalja, MD  Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Scott Knoer, PharmD is the CEO of the American Pharmacists Association. Scott has been very vocal about the FDA eliminating barriers to Pharmacists prescribing COVID antivirals and how the American Medical Association (AMA) seeming to be more concerned with their 'turf' and political position compared to the benefit to public health within America. Amesh Adalja, MD wrote in MedPage Today, an article titled: "A Successful 'Test-to-Treat' Program Requires All Hands on Deck" Within the article, Dr. Adalja wrote. In encouraging news, President Biden just announced a new plan to increase faster access: test-to-treat. The plan will enable pharmacies to become one-stop shops for COVID-19 diagnosis and oral antiviral treatment. Having treatment available at the point-of-diagnosis has the potential to significantly improve prescribing rates, which will have the downstream impact of reducing hospitalizations. More sick patients will quickly be able to access treatment. "We can't have a guild-like mentality that seeks to use government force to exclude qualified persons from engaging in a field for which the AMA wants physicians to be the exclusive purveyors. This has been evident in organized medicine's general opposition to expanded practice scopes for nurse practitioners, physician assistants, psychologists, and -- as is clear -- pharmacists. It's bad enough to advocate for this on a day-to-day basis. To do so during a public health emergency, where all hands are needed on deck, is destructive." -- Amesh Adalja, MD  Learn more about your ad choices. Visit megaphone.fm/adchoices

The recent Joe Rogan/Spotify backlash over the misinformation presented in his recent episode on the Covid-19 vaccines raises some difficult and important bioethical questions for society: How can people know which experts to trust? What should big tech gatekeepers do about false claims promoted on their platforms? How should the scientific establishment respond to heterodox viewpoints from experts who disagree with the consensus? When is silencing of dissent merited, and when is it problematic? Journalist Kira Peikoff asks infectious disease physician and pandemic scholar Dr. Amesh Adalja to weigh in. 

A conversation with infectious disease specialist Amesh Adalja MD wherein we discuss the "new" Omicron variant, and where Dr. Adalja weighs on the controversy surrounding Spotify, podcaster Joe Rogan and the efforts to silence his presentation of arguably dangerous countervailing vaccine science.

In this episode, Joel M. Gelfand, MD, MSCE, is joined by Leonard H. Calabrese, DO, and Amesh Adalja, MD, FIDSA, as they discuss quarantine and isolation guidelines, emerging therapies to treat COVID-19, and the anticipated future of the COVID-19 pandemic. Welcome from Joel Gelfand, MD, MSCE :10 About Calabrese and Adalja :11 At day five, what's your recommendation for clinicians how to counsel people about testing to get out of isolation? Do you recommend people go ahead and get tested to end isolation or to just end isolation if not having much symptoms or improving? :51 How should we counsel our immunocompromised patients? Should they really isolate for 20 days? 5:21 Can people continue to test positive and antigen test beyond the infectious period? 10:13 In the clinical setting, you know, should physicians be wearing N95 masks, and if so, what's that databased on? 15:22 If a person has a positive antigen test but a negative PCR on the same day, how do you interpret that information for a patient? 22:12 Now we finally have emergence of effective therapies for people with COVID-19. How do you think about these different therapies? Do you have an algorithm that you'd recommend to clinicians in the field about which one to reach for first? 24:05 When someone has a COVID infection how soon thereafter can you give them a COVID immunization? 27:47 With Omicron working its way through the US and obviously through the world, where do you see the next three to six months going? 28:34 Thank you everyone 31:29 Amesh Adalja, MD, FIDSA,is senior scholar at Johns Hopkins and a practicing infectious disease and critical care physician in Pittsburgh. Leonard H. Calabrese, DO, is chief medical editor of Healio Rheumatology, professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and RJ Fasenmyer Chair of Clinical Immunology at the Cleveland Clinic. Joel M. Gelfand, MD, MSCE, is chief medical editor of Healio Psoriatic Disease and professor of dermatology and epidemiology at the Perelman School of Medicine at the University of Pennsylvania. He is also vice chair of clinical research, medical director at the Dermatology Clinical Studies Unit, and director of the Psoriasis and Phototherapy Treatment Center at Penn Medicine. We'd love to hear from you! Send your comments/questions to Dr. Gelfand, Calabrese and Adalja at covid19podcast@healio.com. Be sure to check Healio.com/coronavirus for daily updates on the pandemic and follow us on Twitter @InfectDisNews, @GoHealio, @DrJoelGelfand, @LCalabreseDO and @AmeshAA. Disclosures: Adalja reports no relevant financial disclosures. Calabrese reports consulting for AstraZeneca, GSK and Regeneron. Gelfand reports serving as a consultant for Abcentra, Abbvie, BMS, Boehringer Ingelheim, GSK, Lilly (DMC), Janssen Biologics, Novartis Corp, UCB (DSMB), Neuroderm (DSMB), Trevi, and Mindera Dx., receiving honoraria; and receives research grants (to the Trustees of the University of Pennsylvania) from Boehringer Ingelheim, and Pfizer Inc.; and received payment for continuing medical education work related to psoriasis that was supported indirectly pharmaceutical sponsors. Gelfand is a co-patent holder of resiquimod for treatment of cutaneous T-cell lymphoma. Gelfand is a deputy editor for the Journal of Investigative Dermatology receiving honoraria from the Society for Investigative Dermatology, is chief medical editor for Healio Psoriatic Disease (receiving honoraria) and is a member of the Board of Directors for the International Psoriasis Council, receiving no honoraria.

As we enter our third year of the COVID-19 pandemic, many Americans are beginning to wonder is there an endemic in sight. This week, Jared spoke with Senior Scholar at the Johns Hopkins Center for Health Security, Dr. Amesh Adalja to discuss the projected timeline of how the nation will continue to combat COVID-19. Dr. Adalja also discusses how alleviating vaccine hesitancy could be a game changer to establishing a sense of normalcy while living with this pandemic. We're two weeks in to an 11 month news cycle focusing on the November midterm elections, candidacies are beginning to be announced. This week, Jared speaks with Managing Editor of Sabato's Crystal Ball, Kyle Kondik to discuss what's expected from both the Houses of Congress. Kyle notes that Republican enthusiasm appears to be high, while Democrats seem to be scrambling for solid candidates.

As we enter our third year of the COVID-19 pandemic, many Americans are beginning to wonder is there an endemic in sight. This week, Jared spoke with Senior Scholar at the Johns Hopkins Center for Health Security, Dr. Amesh Adalja to discuss the projected timeline of how the nation will continue to combat COVID-19. Dr. Adalja also discusses how alleviating vaccine hesitancy could be a game changer to establishing a sense of normalcy while living with this pandemic. We're two weeks into an 11-month news cycle focusing on the November midterm elections, candidacies are beginning to be announced. This week, Jared speaks with Managing Editor of Sabato's Crystal Ball, Kyle Kondik to discuss what's expected from both the Houses of Congress. Kyle notes that Republican enthusiasm appears to be high, while Democrats seem to be scrambling for solid candidates. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of New Ideal Live, Agustina Vergara Cid interviews Amesh Adalja, a well-known expert on pandemic preparedness, about the Omicron variant, the idea of “zero Covid,” and other issues related to the Covid-19 pandemic. Among the topics covered: What Omicron's high transmissibility means for hospital capacity;How government Covid policies have changed from the early months of the pandemic;The problem with focusing on case numbers rather than hospitalizations and deaths;The merit of a harm-reduction approach to Covid-19 versus an “abstinence only” approach;Why the virus that causes Covid-19, unlike the measles virus, cannot be eliminated;The effectiveness of the currently available vaccines against Omicron;The benefits of vaccine boosters for different populations;Whether measuring every patient hospitalized “with Covid” is a good indication of hospital capacity;Omicron's effect on children and the value of pediatric vaccination;The next generation of Covid-19 vaccines;The protection offered by natural immunity before and after the arrival of Omicron;The merits of Paxlovid and other antiviral therapeutics;What explains the unavailability of Covid-19 tests, and their effectiveness at detecting Omicron;The validity of the CDC's new recommended isolation period. Mentioned in the discussion is Adalja's article “‘Abstinence only' approach to COVID failed in 2021 — missed opportunity for teaching harm reduction,” published in The Hill. The podcast was recorded on January 5, 2022. Listen to the discussion below. Listen and subscribe from your mobile device on Apple Podcasts, Google Podcasts, Spotify or Stitcher. Watch archived podcasts here. https://youtu.be/X5zJe_UQLzA Podcast audio:

Dave Levinthal joins the show Replay of Dr Amesh Adalja from Thursdays BMaz and Beamer

Dr. Amesh Adalja a physician specializing in infectious disease and a senior scholar at the John's Hopkins Center for HealthSecurity , discusses the COVID l9 pandemic and the state of the health field's efforts to arrest it. Dr. Adalja weighs in on the Omicron variant, the success of COVID vaccination programs, and other treatment options beyond the vaccine. Finally Adalja opines that a universal Coronavirus vaccine for ALL strains is not just a dream but a realizable reality.

Dr. Amesh Adalja of John's Hopkins says COVID IHU variant also known as 640 has been on the radar for months, with limited infections. However it is worth watching since it is yet another variant besides delta, omicron and others and evidences the mutability of the virus.

Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. We discuss his views on the pandemic - what we got right and what we got wrong - and how we can be better prepared in the future.

This episode is sponsored by: —Masterworks: expand your investment portfolio with fine art. Visit https://www.masterworks.art/mp —BetterHelp: get 10% off your first month at https://betterhelp.com/peterson and join over 2M people who have taken charge of their mental health In this episode of Opposing Views, I was joined by Robert F.. Kennedy Jr. and Amesh Adalja to discuss the safety of vaccines, more specifically the Covid19 vaccines. We covered a range of topics including childhood vaccination, the recommended vaccine schedule in the US, vaccine types, safety, additives, and injuries, and much more. Robert F. Kennedy Jr. is the chairman and founder of Children's Health Defence. He's the author of a new book: The Real Anthony Fauci. He is also the son of the late Senator Robert F. Kennedy and nephew of the late President John F. Kennedy. Amesh Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. If you enjoyed this episode, be sure to hit subscribe! - Find more Robert F. Kennedy on Twitter @RobertKennedyJr https://twitter.com/RobertKennedyJr Find more Amesh Adalja on Twitter @AmeshAA https://twitter.com/AmeshAA

Kevin Hardwick joins the show. We playback Fridays interview with Dr Amesh Adalja. See omnystudio.com/listener for privacy information.

#Like what you hear? Like, share, and subscribe to stay updated on new videos and help promote the Yaron Brook Show: https://bit.ly/3ztPxTxBecome a sponsor to get exclusive access and help create more videos like this: https://bit.ly/2TCEqHcOr make a one-time donation: https://bit.ly/2RZOyJJContinue the discussion by following Yaron on Twitter (https://bit.ly/3iMGl6z) and Facebook (https://bit.ly/3vvWDDC )Want to learn more about Ayn Rand and Objectivism? Visit the Ayn Rand Institute: https://bit.ly/35qoEC3 #Omicron #Covid19 #Vaccines #Pfizer #AynRand #Objectivism #Ethics #Politics

Dr. Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. See omnystudio.com/listener for privacy information.

Senior Scholar at the Johns Hopkins University Center for Health Security, Dr. Amesh Adalja, joins Dr. Marc Siegel and discusses COVID vaccines, boosters, the complexity of measuring COVID-19 immunity, and why he believes there is a need to make messaging for COVID-19 goals more clear.

If a vaccinated person is exposed to COVID but doesn't get sick, does that affect that person's immunity? Is weekly testing for unvaccinated coworkers really sufficient to protect everyone? Are any new variants keeping you up at night? Should people switch vaccines for their booster doses? Amesh Adalja of the Johns Hopkins Center for Health Security and Josh Sharfstein address COVID-19 questions submitted to publichealthquestion@jhu.edu.

In late October, experts in the US stopped talking about taking extreme precautions against Covid-19 and started talking about learning to live with the virus. Does this represent a change of heart or a change in the science? It's been hard for experts to detangle their scientific opinions from their feelings and values. In this episode I'll talk with Amesh Adalja, a senior scholar at the Johns Hopkins School of Public Health. He's long advocated an approach called harm reduction, which was used in the AIDS crisis to help guide people toward having safer sex rather than asking them to give it up forever. He says many experts initially pushed a Covid-19 strategy akin to abstinence only, but it's becoming more obvious by the day that this is unsustainable, and the virus isn't going away. “Follow the Science" is produced, written, and hosted by Faye Flam, with funding by the Society for Professional Journalists. Today's episode was edited by Seth Gliksman with music by Kyle Imperatore. If you'd like to hear more "Follow the Science," please like, follow, and subscribe!

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

Listen as farmer Anita Ashok Adalja lets us in on what it's like to grow okra in the Southwest, including how to “convince” neighbors to try a new-to-them vegetable.  Learn about the Not Our Farm farmworker visibility project, telling the story of and celebrating folks who are non-farm-owning and working on others' farms. Find out how to have your own story told and hear about the farmworkers guide that's about to be released. Dig in to food safety for your small farm with advice from Anita's place as a farmer as well as a food safety educator. Spoiler alert: If you think about food safety from the perspective of healthy community care, it's a much less intimidating concept—and you're likely already doing it. Tune in to Anita's hope for the concept of revisioning how sustainable farming fits into our lives. Stay tuned to the end to learn Anita's trick for cooking okra so it's not slimy! And add her favorite okra recipe to your upcoming meal plan. 

In this episode of New Ideal Live, Ben Bayer interviews Dr. Amesh Adalja, a well-known expert on pandemic preparedness, about the resurgence of Covid infections around the country due to the Delta variant and how vaccines are holding up against the virus. Among the topics covered: What the Delta variant is and how it behaves;Whether vaccination against Covid-19 helps decouple infection rates from hospitalization and death;How long the Delta surge of infections might last in the U.S.;The issue of “breakthrough infections” in fully vaccinated people;Why vaccines do not by their nature prevent any and all infection;Whether the Biden administration was right to recommend booster shots for all adults;How the Delta variant is affecting children, and when they might be vaccinated;What measures should be considered to protect children at schools;Whether hospitals should require vaccines for health care workers,How Dr. Adalja calculates risk when deciding on activities that may expose him to infection;The themes of Dr. Adalja's upcoming talk at OCON 2021;The Covaxin Covid vaccine;Whether ivermectin and fluvoxamine are viable treatments for Covid-19;The difference between natural immunity after infection and vaccine-induced immunity, and how they complement each other;The potential to develop “long Covid” after “breakthrough infections.” Mentioned in the discussion is Onkar Ghate's paper “A Pro-Freedom Approach to Infectious Disease.” Dr. Adalja will be speaking at this year's Objectivist Conference (August 27 – September 1). You can purchase a virtual pass to attend the conference online here.  This podcast was recorded on August 25, 2021. Listen to the discussion below. Listen and subscribe from your mobile device on Apple Podcasts, Google Podcasts, Spotify or Stitcher. Watch archived podcasts here. https://youtu.be/3DVGYb9S8XQ Podcast audio:

This week, Bailey and Tyler ask the question: how risky is it to attend concerts? A recent interview done by the people at Billboard this week helped answer just that by talking to an infectious disease expert Dr. Amesh A. Adalja. They give you the gist of the interview while trying to help out any concert-goers that may feel uneasy or unsure about the safety of concerts.Before they get to that, the crew  runs through some interesting music news, then they talk about State Champs' new teaser for their upcoming "Just Sound" song, as well as give their takes on new music released this week from Noahfinnce, Save Face, Yungblud, Doll Skin, happydaze, Real Friends and Royal Blood.Source: Billboard (https://www.billboard.com/articles/business/touring/9616439/concerts-safe-vaccinated-people-infectious-disease-expert-advice/)Want to hear the new music we discussed this week? We've got them here: https://open.spotify.com/playlist/703qte0myFr6bmwHkglJob?si=05a86949803447c0Sign-up for our weekly newsletter!http://allpunkedup.com/subscribeSupport the show (https://www.paypal.com/donate/?hosted_button_id=KR8HCDXCGWB88)

I am fully vaccinated with the Moderna vaccine. If I catch the delta variant will I acquire additional immunity—in addition to the immunity to the vaccination? If I received the COVID-19 vaccine and I'm now breastfeeding, will my baby receive antibodies? Do masks get less effective depending on how long they're worn? Dr. Amesh Adalja of the Johns Hopkins Center for Health Security addresses your questions submitted to publichealthquestion@jhu.edu.

Join Onkar Ghate for an interview and Q&A panel with Amesh Adalja—a world expert on infectious disease and pandemic preparedness—about issues related to the Covid-19 pandemic and infectious disease outbreaks more broadly.Recorded on May 16, 2020 as part of OCON Live! 2020

Not Our Farm 

It's no surprise that American business was caught flat-footed by the pandemic. And, Dr. Amesh Adalja of the Johns Hopkins Center for Health Security knows that this won't be the last economic and societal disruption. Dr. Adalja knew that a pandemic was just around the corner -- he just didn't know when. In this conversation with the Vanguard Network's Ken Banta, he cautions CEOs to never let their emergency plans gather dust again -- or face the consequences.

On this week's Talking With TD: Turron and Chris Sanders rank their top five running backs in the NFL, Dr. Amesh Adalja joins the show to discuss vaccine effectiveness and how that will look in the NFL and Titans DL Larrell Murchison also talks shop with TD in the final segment!

We are back with our guest host, Shar Jossell!  Today we unpack the history of pronouns as we continue to show awareness to our non-binary friends. In What's Trending in the news, we discuss if Democrats leaving TX in an effort to block Republicans from passing a restrictive new voting law  will work! Plus, we bring you your traveling advice and so much more!  Let's go there!   Special guests: David Weigel -  Political Reporter David Weigel for The Washington Post Sahil Kapur - National Political reporter for NBC News Amesh A. Adalja, M.D. - Senior scholar at the Johns Hopkins Center for Health Security Dennis Baron - Prof. of English and linguistics, emeritus, at the University of Illinois, and author of the book What's your pronoun? Beyond he and she  Hannah Sampson - Staff writer at The Washington Post for By The Way, where she reports on travel news. See omnystudio.com/listener for privacy information.

Boris Johnson has announced a wholesale "bonfire" of Covid-19 rules with a new plan to get England to live with the virus.The British Prime Minister has announced almost all restrictions, including gathering limits, mask mandates, social distancing rules and work from home guidelines, will no longer apply from July 19.That's despite rising cases of the more infectious Delta strain, across the UK and parts of Europe.New Zealand, meanwhile, is continuing to stick to the elimination strategy. Covid-19 Response Minister Chris Hipkins told RNZ that the country needs to "work hard over the next little while, the next probably couple of years" to keep Covid-19 out. Amesh Adalja, infectious diseases expert from Johns Hopkins University, told Heather du Plessis-Allan this is the wrong strategy."It is not something that can be eliminated or eradicated. This is something we want to tame with vaccine in high-risk populations, and possibly make similar to other respiratory viruses that we deal with."He says that island nations may think they can keep it out, but "it is not going anywhere", and sustainable approach that allows life to continue is more realistic, and our population will need to be educated about that. "I think the New Zealand, Australia approach isn't reflective of that." LISTEN ABOVE

Like​ what you hear? Like, share, and subscribe to stay updated on new videos and help promote the Yaron Brook Show: http://youtube.com/ybrook​​​​Become a sponsor to get exclusive access and help create more videos like this: http://yaronbrookshow.com/support​​​​Or make a one-time donation: http://paypal.me/yaronbrookshow​​​​Continue the discussion by following Yaron on Twitter (http://twitter.com/yaronbrook​​​​) and Facebook (http://facebook.com/ybrook​​​​). Want to learn more about Ayn Rand and Objectivism? Visit the Ayn Rand Institute: http://ari.aynrand.org​​#Delta #Ivermectin #Covid #Moderna #Pfizer #Objectivism​ #AynRand

John Scholes & I are absolutely honoured and thrilled to have scored a special edition interview with Senior Scholar & Infectious Disease Expert Dr Amesh Adalja, from John Hopkins Centre for Health Security, .Listen live tomorrow on @sauga960am ( Wednesday) from 11am to 12pm to our show with Dr Adalja who answers questions from vaccines to conspiracy theories to future pandemics and how we can prepare for them .One hour show dedicated to COVID19 FACTS starting with our money guy Geoff MacGillvary to dispel myths that insurance companies won't cover COVID19 cases to the BIG interview with Dr Adalja.MUST LISTEN TO SHOW **ONLINE or LIVE on air **

In this episode of New Ideal Live, Agustina Vergara Cid interviews Amesh Adalja, a well-known expert on pandemic preparedness, about the fight against the pandemic in the U.S. and around the world. Among the topics covered: Evidence of the safety of the Covid-19 vaccines available in the U.S.;Whether reaching “herd immunity” is relevant to ending the current pandemic;What explains the recent CDC guidelines about masks;“Breakthrough infections” among the already vaccinated;Covid outbreaks overseas and U.S. measures to help contain them;Recent and upcoming developments with vaccines;The story of the development of mRNA vaccines;Whether travel bans help prevent the spread of viruses like Covid;Lessons from South Korea’s and Taiwan’s approaches to the pandemic;How to evaluate medical experts. Mentioned in the discussion are Amesh Adalja’s recent article “With vaccinations on the rise, Covid-19 testing takes on a new role” and Onkar Ghate’s white paper, “A Pro-Freedom Approach to Infectious Disease.” This podcast was recorded on May 19, 2021. Listen to the discussion below. Listen and subscribe from your mobile device on Apple Podcasts, Google Podcasts, Spotify or Stitcher. Watch archived podcasts here. Podcast audio:

Communal Violence Inside of Israel May Restrain Escalation to an Invasion of Gaza | Fully-Vaccinated Americans Can Now Take Off Their Masks | The GOP is Getting More Extreme and Will Dismantle Democracy if They Win in 2022 backgroundbriefing.org/donate twitter.com/ianmastersmedia facebook.com/ianmastersmedia

In my 18th episode, I spoke with Dr. Amesh Adalja, Senior Scholar at the Johns Hopkins Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. We talked about COVID-19 and where we are right now as people get vaccinated while variants are spreading at the same time across the world. We also discussed his career and his thoughts on how to move forward in a way that improves our healthcare system and makes us better prepared for future pandemics.

Working non-stop to communicate COVID-19 news to the public has given Dr. Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, an inside look at the pandemic from both a clinical and policy perspective. The new public scrutiny he has drawn has come with criticism and even hate mail. In this episode, Adalja reflects on partisanship, the authority of public health experts and the CDC, WHO reform, and his on-the-ground experience in a public health crisis.Watch the full interview.This interview was recorded on January 18, 2021

Check out our guests for this episode of the 1Hood Power Hour!- Dr. Amesh Adalja: Senior Scholar Johns Hopkins Ctr for Health Security, discussing what to expect in the response to the pandemic as the vaccine continues to roll out, new variant strains emerge and a new administration takes office- State Senator Jim Brewster 45th District: Recently was finally seated in PA's State Senate after winning re-election and several legal battles to uphold his election win.- Mayor Matt Shorraw of Monessen, PA: Just passed an ordinance forbidding discrimination in housing and employment based on sexual orientation and gender identity and expression.

Reopening Delaware segments from The Rick Jensen Show - Dr. Adalja, MD, is a Senior Scholar at the Johns Hopkins University Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. He explains to Rick why research shows face shields can be better than face masks.

What are the second- and third-order implications of COVID-19? Listen to Jason Mitchell discuss with Dr. Amesh Adalja, Senior Scholar at the Johns Hopkins University Center for Health Security, about the tragic irony of US and UK pandemic preparedness, what to make of antiviral and vaccine game changers, centralised versus de-centralised policy responses and why pandemic preparedness could well be a major political platform issue in the next electoral cycle. For more information visit www.man.com/maninstitute/responsible-investment This podcast was recorded on 06 May 2020. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Adalja is a Senior Scholar at the Johns Hopkins University Center for Health Security. His work is focused on emerging infectious disease, pandemic preparedness, and biosecurity. I am honored to be able to publish this in a time in which all of the education field is reeling with the possibility that school might be … Continue reading "Episode 33: Risk Assessment for Group Activities with Dr. Amesh Adalja of Johns Hopkins Center for Health Security"

On the most recent episode of Outbreak News TV on YouTube, I talk to Senior Scholar at the Johns Hopkins Center for Health Security, Amesh Adalja, MD. He was named one of STAT's "13 Clinicians to Follow on Twitter and in 2015 named one of 5 "Pennsylvanians to Watch" by the Pittsburgh Tribune Review. We discuss medicine and the media, the problem of vaccine hesitancy, antibiotic resistance and mosquito borne illness. I also ask him his thoughts on some issues about Lyme disease, pandemic flu and more.

News of North Carolina's largest chickenpox outbreak since the vaccine was available 23 years ago was reported in an Asheville school, which has grabbed a lot of attention recently. Closer to home, a chickenpox outbreak has been reported in a Polk County, Fl school where a half dozen children were infected. The common denominator among the cases is not being vaccinated. Joining me to talk about chickenpox and why we are still having outbreaks is Amesh Adalja, MD. Dr Adalja is a Senior scholar at the Johns Hopkins Center for Health Security and an infectious disease expert.

The Food and Drug Administration and the Texas Department of Health recently issued health alerts after four infants were hospitalized with botulism after using pacifiers containing honey. While essentially rare worldwide, ninety percent of the world's cases of infant botulism are diagnosed in the United States, mainly because of physician awareness. So what is infant botulism and why should infants avoid honey? Joining me to answer these questions and more is Amesh Adalja, MD. Dr Adalja is a Senior scholar at the Johns Hopkins Center for Health Security and an infectious disease expert.

A rehab facility in Haskell NJ has been in the news cycle for the past week as they deal with an adenovirus outbreak. To date, 26 cases have been reported, primarily pediatric patients and nine have died. What is adenovirus and why the high percentage of deaths in this outbreak? Joining me to answer these questions is Amesh Adalja, MD. Dr Adalja is a Senior Scholar at the Johns Hopkins University Center for Health Security.

A recent Reuters article on the problem with Venezuela's measles outbreak crossing the Brazilian border said the following: Brazil complained on Thursday that Venezuela was doing nothing to stop the spread of an outbreak of measles in Brazil and other neighboring countries that has been sparked by an exodus of Venezuelans fleeing economic collapse. This has prompted Brazil to launch a nationwide campaign to vaccinate 11 million children, plus adults who request it. My guest today commented on Twitter writing--Totalitarian governments, not surprisingly, spawn infectious disease outbreaks that place other countries at risk. Joining me today is Amesh Adalja, MD. Dr Adalja is a Senior Scholar at the Johns Hopkins Center for Health Security and a recognized expert in infectious diseases.

Fads and movements on what we do and don't put in our bodies seem to plague the US and latest one has originated out of California. There has been a huge demand in Silicon Valley for very expensive “raw water”. Raw water is supposedly unfiltered, untreated, unsterilized spring water according to a NY Times report. The rationale is that the existing water supply and tap water has many chemicals and pollutants and naturally occurring minerals that are filtered out when water is treated. What about this trendy fad and what are the health risks? Amesh Adalja, MD joined me to talk about raw water. Dr Adalja is a Senior Associate with the Johns Hopkins Center for Health Security.

Since the Haiti cholera outbreak began in October 2010, months after the Jan. 12, 2010 earthquake, more than 800,000 cases have been reported, including about 9500 deaths. Although the numbers have decreased dramatically over the years, the island nation still sees thousands of cases annually. Today, cholera outbreaks are reported in Kenya, Nigeria, the DRC , Tanzania and most notably Yemen where more than 360,000 suspected cases, including 1800+ deaths have been reported in the past three months. In fact, according to the humanitarian organization, Oxfam, the number of people with cholera in Yemen is now the largest ever in any country in a single year since records began, topping the previous annual record of 340,311 in Haiti in 2011. Amesh Adalja, MD joined me to discuss cholera. Dr. Adalja is a Senior Associate with the Johns Hopkins Center for Health Security.

The Centers for Disease Control and Prevention (CDC) says “Hepatitis” means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis. However, hepatitis is most often caused by a virus. In the United States, the most common types of viral hepatitis are Hepatitis A, Hepatitis B, and Hepatitis C. Hepatitis A has been in the news with some frequency as significant outbreaks have been reported in the Detroit and San Diego areas and Europe is experiencing a big outbreak. Senior Associate with the Johns Hopkins Center for Health Security, Amesh Adalja, MD joined me to answer some questions about hepatitis A.